News

BioSpace12m

Weight-Loss Wasteland: 5 Obesity Assets That Failed

The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...

Weight-loss patients taking Zepbound forced to switch to Wegovy after drop in coverage

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Pentagon Drops Coverage of GLP-1 Weight Loss Meds for Medicare-Eligible Retirees

Tricare officials said the Defense Health Agency is eliminating coverage for its Tricare for Life beneficiaries and others to ...

To stay on weight-loss drugs, US patients cut doses and maybe vacations

Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...

Popular weight-loss medication could relieve painful arthritis symptoms, doctors report

Medical professionals observe that GLP-1 medications like Ozempic show promise for treating rheumatoid arthritis alongside ...

Novo Nordisk to sell weight-loss drug for $499 to eligible customers

Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through ...
Total Pro Sports3d

Serena Williams Spills The Beans On Using Drug To Lose 31-Pounds After Receiving Criticism For Her Looks

Serena Williams reveals a 31-pound weight loss with Zepbound after fan concern, crediting the drug for transforming her ...
Baller Alert on MSN6d

Ozempic and Zepbound Lawsuits Explode: Patients Say Popular Weight-Loss Drugs Left Them Hospitalized

More than 2,000 lawsuits are now targeting the makers of Ozempic and Zepbound, with patients claiming the drugs caused dangerous and sometimes permanent health problems. The cases, consolidated in ...